We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
C225 and PJJT Combination Therapy for Ovarian Cancer: The Play's the Thing.
- Authors
Cengel, Keith A.; Hahn, Stephen M.; Glatstein, Eli
- Abstract
Comments on a study on the use of C225, a humanized murine monoclonal antibody directed against the epidermal growth factor receptor (EGFR), and photodynamic combination (PDT) therapy for ovarian cancer. Drug administration; Mechanism of action; Advantages of the medications when used separately; Complexities associated with the interactions between EGFR and PDT.
- Subjects
PHARMACODYNAMICS; MONOCLONAL antibodies; EPIDERMAL growth factor; COMBINATION drug therapy; GYNECOLOGIC cancer; TREATMENT of diseases in women
- Publication
JNCI: Journal of the National Cancer Institute, 2005, Vol 97, Issue 20, p1488
- ISSN
0027-8874
- Publication type
Editorial
- DOI
10.1093/jnci/dji360